Organoidsciences Ltd. (KOSDAQ:476040)
South Korea
· Delayed Price · Currency is KRW
44,450
+3,650 (8.95%)
At close: Dec 5, 2025
Organoidsciences Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -13,834 | -11,246 | -38,687 | -24,111 |
| Depreciation & Amortization | 1,304 | 1,304 | 1,144 | 804.46 |
| Loss (Gain) From Sale of Investments | -163.05 | -163.05 | -43.05 | - |
| Stock-Based Compensation | 969.5 | 969.5 | 979.19 | 542.39 |
| Other Operating Activities | -51.83 | 79.15 | 29,853 | 13,990 |
| Change in Accounts Receivable | 149.39 | 149.39 | -393.5 | 0.78 |
| Change in Inventory | 26.82 | 26.82 | -26.23 | - |
| Change in Accounts Payable | 0.74 | 0.74 | 14.88 | - |
| Change in Income Taxes | - | - | 0.74 | - |
| Change in Other Net Operating Assets | -529.07 | -260.43 | -90.48 | 256.22 |
| Operating Cash Flow | -12,128 | -9,141 | -7,248 | -8,518 |
| Capital Expenditures | -1,462 | -667.07 | -947.83 | -1,787 |
| Sale of Property, Plant & Equipment | - | - | 6.16 | - |
| Sale (Purchase) of Intangibles | -45 | -120.21 | -70.5 | -16.88 |
| Investment in Securities | -11,523 | 5,761 | 5,632 | -25,434 |
| Other Investing Activities | -25.65 | -48.27 | -19.93 | -1,094 |
| Investing Cash Flow | -13,055 | 4,925 | 4,600 | -28,332 |
| Short-Term Debt Issued | - | 3,000 | - | 300 |
| Long-Term Debt Issued | - | 700 | - | - |
| Total Debt Issued | 3,700 | 3,700 | - | 300 |
| Short-Term Debt Repaid | - | -300 | - | - |
| Long-Term Debt Repaid | - | -217.49 | -218 | -231.04 |
| Total Debt Repaid | -378.63 | -517.49 | -218 | -231.04 |
| Net Debt Issued (Repaid) | 3,321 | 3,183 | -218 | 68.96 |
| Issuance of Common Stock | 24,911 | 200 | 250 | - |
| Other Financing Activities | 646.51 | 280.79 | 148.42 | 218.27 |
| Financing Cash Flow | 28,879 | 3,663 | 180.43 | 11,286 |
| Foreign Exchange Rate Adjustments | -115.69 | 44.82 | -74.93 | - |
| Net Cash Flow | 3,581 | -507.22 | -2,543 | -25,563 |
| Free Cash Flow | -13,590 | -9,808 | -8,196 | -10,304 |
| Free Cash Flow Margin | -533.84% | -502.11% | -515.13% | -2351.33% |
| Free Cash Flow Per Share | -2393.18 | -2346.59 | -2859.93 | -3595.68 |
| Cash Interest Paid | 335.79 | 301.32 | 341.67 | 123.02 |
| Cash Income Tax Paid | - | -34.04 | 114.09 | - |
| Levered Free Cash Flow | -7,831 | -68,924 | 15,049 | - |
| Unlevered Free Cash Flow | -7,611 | -66,930 | 18,794 | - |
| Change in Working Capital | -352.11 | -83.47 | -494.59 | 257 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.